Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

Report Code: PHM199A

Publish Date: Apr 2018

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.

Report Includes

  • 96 data tables.
  • Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
  • Coverage of types of urinary incontinence such as urge incontinence (UUI), stress incontinence (SUI), overflow incontinence (OUI), functional incontinence (FUI), and mixed symptoms (MUI)
  • Identification of effective treatment options for incontinence and overactive bladder
  • Analyses of Idiopathic bladder overactivity and neurogenic bladder overactivity and their probable causes
  • Detailed profiles of key competitors of the market, including Astellas Pharma Inc., Pfizer, Inc., Allergan, PLC., Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S

Report Scope

This research report categorizes the drugs for urinary incontinence and overactive bladder by type. Product type include idiopathic bladder overactivity, and neurogenic bladder overactivity.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022179Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Drugs for Urinary Incontinence and Overactive Bladder Market Characteristics3Free
Chapter- 4: Drugs for Urinary Incontinence and Overactive Bladder Market Size and Growth6Free
Chapter- 5: Drugs for Urinary Incontinence and Overactive Bladder Market Trends and Strategies2Free
Chapter- 6: PESTLE Analysis4Free
Chapter- 7: Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation6Free
Chapter- 8: Drugs for Urinary Incontinence and Overactive Bladder Market: Regional and Country Analyses10Free
Chapter- 9: Drugs for Urinary Incontinence and Overactive Bladder Market Customer Information2Free
Chapter- 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market Comparison with Macro Economic Factors2Free
Chapter- 11: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market9Free
Chapter- 12: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis24Free
Chapter- 13: Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 14: UK Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis25Free
Chapter- 15: Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 16: Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5Free
Chapter- 17: North America Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 18: North America Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5Free
Chapter- 19: South America Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 20: South America Drugs for Urinary Incontinence and Overactive Bladder Market: Country Analysis5Free
Chapter- 21: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 22: Africa Drugs for Urinary Incontinence and Overactive Bladder Market8Free
Chapter- 23: Drugs for Urinary Incontinence and Overactive Bladder Market: Competitive Landscape11Free
Chapter- 24: Key Mergers and Acquisitions in the Drugs for Urinary Incontinence and Overactive Bladder Market1Free
Chapter- 25: Appendix3Free

Related Reports

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Renal Disease Treatments: Products and Therapies

Published - Jun 2016 | Publisher - Cheng-Yuk Lee | Code - HLC073B

The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022
Customize Report